Axsome Therapeutics (AXSM) Assets (2022 - 2025)
Historic Assets for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $669.2 million.
- Axsome Therapeutics' Assets rose 1919.86% to $669.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $669.2 million, marking a year-over-year increase of 1919.86%. This contributed to the annual value of $568.5 million for FY2024, which is 335.55% down from last year.
- Per Axsome Therapeutics' latest filing, its Assets stood at $669.2 million for Q3 2025, which was up 1919.86% from $639.8 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Assets registered a high of $669.2 million during Q3 2025, and its lowest value of $88.6 million during Q1 2022.
- For the 4-year period, Axsome Therapeutics' Assets averaged around $483.9 million, with its median value being $561.5 million (2024).
- As far as peak fluctuations go, Axsome Therapeutics' Assets skyrocketed by 33945.11% in 2023, and later tumbled by 1036.76% in 2024.
- Axsome Therapeutics' Assets (Quarter) stood at $331.5 million in 2022, then surged by 77.46% to $588.2 million in 2023, then dropped by 3.36% to $568.5 million in 2024, then rose by 17.72% to $669.2 million in 2025.
- Its Assets was $669.2 million in Q3 2025, compared to $639.8 million in Q2 2025 and $596.7 million in Q1 2025.